Pulmonary Fibrosis Pipeline Insights Report, 2024: Analyzing the Evolving Landscape of Pulmonary Fibrosis Clinical Development and Market Growth
April 16, 2024 09:22 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Pulmonary Fibrosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report outlays comprehensive...
Leading Companies like Roche and Novartis at the Helm of the Global Rapidly Expanding IPF Treatment Market to 2030
September 26, 2023 05:23 ET
|
Research and Markets
Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ...
Idiopathic Pulmonary Fibrosis Market to Surpass US$ 7,521.2 Million by 2030, Says Coherent Market Insights (CMI)
May 25, 2023 09:01 ET
|
CMI
Burlingame, May 25, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global idiopathic pulmonary fibrosis market is estimated to be valued at US$ 3,853.6 million in 2022 and is...
Global Idiopathic Pulmonary Fibrosis Treatment Market Report 2020: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2014-2025
December 10, 2020 04:33 ET
|
Research and Markets
Dublin, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added...
Pulmonary Fibrosis Treatment Market Value Projected to Reach ~US$ 4.4 Bn by 2029 – PMR
September 05, 2019 09:05 ET
|
Persistence Market Research Private Limited
New York, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Globally, increasing diagnosis rate for the pulmonary fibrosis is expected to drive the growth of the pulmonary fibrosis treatment market. According to...